XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING CASH FLOW    
Net loss $ (65,344) $ (44,753)
Adjustments to reconcile net loss to operating cash flow:    
Depreciation 1,172 1,215
Amortization of intangibles 89 89
Equity-based compensation expense 8,090 2,132
Change in fair value of warrant liabilities (6,091) (6,120)
Net noncash change in right of use assets and lease liabilities 10 803
Changes in assets and liabilities:    
Prepaid expenses and other assets (2,567) (2,597)
Accounts receivable (13,721) (10,168)
Long-term contract work in process (23,900) 0
Accounts payable and accrued expenses 327 1,685
Lease liability (720) (812)
Deferred revenue 22,923 (621)
Accrued compensation (2,635) (4,905)
Net cash used in operating activities (82,367) (64,052)
INVESTING CASH FLOW    
Sale of short-term investments 50,000 0
Purchases of property, plant and equipment (1,620) (1,581)
Net cash provided by (used in) investing activities 48,380 (1,581)
FINANCING CASH FLOW    
Proceeds from Transaction, net 0 341,462
Payments of Transaction costs 0 (2,401)
Proceeds from exercise of common unit options 0 847
Repurchase of common units 0 (566)
Issuance of treasury units 0 20
Proceeds from exercise of warrants and common share options 4,371 0
Net cash provided by financing activities 4,371 339,362
Net change in cash and cash equivalents (29,616) 273,729
Cash and Cash Equivalents [Abstract]    
Beginning of period 244,217 77,094
End of period 214,601 350,823
Summary of noncash investing and financing activities:    
Assumption of Transaction warrant liabilities 0 47,532
Debt converted to equity 0 14,181
Conversion of equity options to liability award 0 50
Plant, property and equipment in accounts payable $ 19 $ 0